Please ensure Javascript is enabled for purposes of website accessibility

The Smartest Dividend Stocks to Buy With $400 Right Now

By Keith Speights - May 30, 2021 at 5:55AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Four Benjamins will get you strong dividends and solid growth with these stocks.

Warren Buffett didn't start out investing with $108 billion. Like every other successful investor, he began his career with a much smaller amount than he has now. 

You don't have to have a lot of money to begin investing. A few hundred dollars should allow you to buy several solid stocks. And investing in the stocks of companies that pay dividends will allow you to receive steady returns on your investment.

But which stocks are good candidates for investors on a relatively tight budget? Here are my picks for the smartest dividend stocks to buy with $400 right now.

Four $100 bills.

Image source: Getty Images.

AbbVie

Let's start the list with a respected Dividend AristocratAbbVie (ABBV -0.24%) has increased its dividend for 49 consecutive years. Since separating from Abbott in 2013, the big drugmaker has boosted its dividend payout by an impressive 225%. Its dividend yield currently stands at nearly 4.6%. And you can buy one share of AbbVie right now for less than $115.

For a long time, the main reason to consider buying AbbVie (other than its dividend) was the growth generated by Humira. The autoimmune disease drug is the company's top-selling product. It even ranked as the best-selling drug in the world for several years.

However, Humira's sales will soon decline as biosimilars hit the U.S. market beginning in 2023. Don't worry: AbbVie's dividend will remain safe. The company's growth won't be disrupted for very long, either. AbbVie expects overall revenue will dip in 2023 but return to growth the following year with strong growth throughout the rest of the decade. 

Innovative Industrial Properties

Few dividend stocks are going to give you the kind of growth that Innovative Industrial Properties (IIPR 1.14%) can. The real estate investment trust (REIT) focuses on the medical cannabis industry. IIP's revenue and net income more than doubled year over year in the first quarter of 2021.

One share of IIP will currently cost you close to $180. That investment should pay off nicely over the next several years, though. All IIP needs to do to continue growing is to buy more properties and lease them back to medical cannabis operators. At the company's current pace of these sale-buyback transactions, it will come close to doubling its number of properties within the next five years. 

You'll also get a strong and steadily increasing dividend with IIP as well. Its dividend yield of around 2.9% is actually deceptively low. The REIT has boosted its dividend by a whopping 780% since 2017. However, IIP's share price has skyrocketed even more -- nearly 850% -- during the same period, keeping its dividend yield from rising. 

Brookfield Renewable

One of the trends that you can bank on for the future is the increasing use of renewable energy. Countries and companies around the world are seeking to reduce carbon emissions, boosting the demand for renewable energy in the process. It definitely helps that renewable energy sources like wind and solar are more cost-effective than ever.

I think that using most of the remaining money from your initial $400 to buy a couple of shares of Brookfield Renewable (BEP -0.40%) (BEPC -0.62%) would be a smart move. The company is a leader in the renewable energy industry with 21,000 megawatts of installed capacity, including hydroelectric, wind, and solar facilities. It also has a development pipeline of around 27,000 megawatts.

Note that there are two ways to invest in Brookfield Renewable. The limited partnership (LP) Brookfield Renewable Partners trades under the BEP ticker, while the more tax-friendly Brookfield Renewable Corporation trades under the BEPC ticker. It's the same underlying business with either stock. Both shares currently trade at around $40. Both also pay solid dividends with yields of a little under 3%. 

Keith Speights owns shares of AbbVie, Brookfield Renewable Corporation Inc., Brookfield Renewable Partners L.P., and Innovative Industrial Properties. The Motley Fool owns shares of and recommends Innovative Industrial Properties. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Brookfield Renewable Partners L.P. Stock Quote
Brookfield Renewable Partners L.P.
BEP
$39.66 (-0.40%) $0.16
Abbott Laboratories Stock Quote
Abbott Laboratories
ABT
$110.79 (0.27%) $0.30
AbbVie Inc. Stock Quote
AbbVie Inc.
ABBV
$141.73 (-0.24%) $0.35
Innovative Industrial Properties Stock Quote
Innovative Industrial Properties
IIPR
$97.47 (1.14%) $1.10
Brookfield Renewable Corporation Inc. Stock Quote
Brookfield Renewable Corporation Inc.
BEPC
$41.74 (-0.62%) $0.26

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
389%
 
S&P 500 Returns
125%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/12/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.